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Clinical Outcomes of Physiologically-guided
Revascularisation
Nasir Rahman, Ghufran Adnan, Awais Farhad, Jamshed Ali and Ihsan Ullah
Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan
ABSTRACT
Objective:  To  assess  the  clinical  outcomes  of  revascularisation  based  on  fractional  flow reserve  (FFR)  and/or  instantaneous
wave-free ratio (iFR).
Study Design: Descriptive study.
Place and Duration of Study: Department of Medicine, The Aga Khan University Hospital, Karachi from January 2012 to
January 2020.
Methodology: A cohort of patients having moderate to severe coronary stenosis, undergoing coronary revascularisation based
on invasive physiological assessment (FFR or iFR) were assessed. The participants were divided into the revascularisation-de-
ferred group and the revascularization-performed group, based on the physiological results. Cox-proportional hazard model
building was done, using a stepwise approach by assessing all plausible interactions and considering p-value ≤0.05 as statisti-
cally significant.
Results: The frequency of major adverse cardiac event (MACE) and target vessel revascularisation was 8.4% and 3.2% in the
revascularisation-performed group as compared to 6.4% and 3.2% in the revascularisation-deferred group. In adjusted models,
no statistically significant difference was noted in MACE when comparing the revascularisation-performed group with a deferred
group.
Conclusion: Revascularisation guided by invasive physiological assessment with FFR or iFR is clinically safe and led to better
resource utilisation.
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INTRODUCTION
Coronary  artery  disease  (CAD)  has  emerged  as  the  most
common  cause  of  death  in  low-middle  income  countries,
including Pakistan.1,2 Coronary angiography has been the gold
standard test to assess coronary stenosis; however, it explains
the location and severity of stenosis only anatomically.3 There is
also significant inter-observer and intra-observer variability in
the reporting of stenoses. Recently introduced ancillary tests
like fractional flow reserve (FFR) and instantaneous wave-free
ratio (iFR) are significant tools for assessing the physiological
significance of these stenosis.4,5 Physiological assessment of
anatomically  intermediate-to-severe stenosis,  using iFR and
FFR, has also been proven to reduce both the number of stents
used and major adverse cardiac events.6-8
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There is a higher prevalence of diabetes and multiple vessel
coronary artery disease among the South-Asian population.9,10
Most of the studies on the use and outcomes of FFR/iFR have
been conducted on the European/North American population.
Consequently, there is a paucity of data on the utilisation and
outcomes of FFR and iFR in the South-Asian population.11
METHODOLOGY
A longitudinal descriptive study was conducted from January
2012 to January 2020 in a cohort of patients with moderate to
severe coronary stenosis at The Aga Khan University Hospital,
Karachi. Patients in whom follow-up was not available and those
who refused to undergo revascularisation after positive physio-
logical  assessment,  were  excluded.  A  final  sample  of  499
patients was included in the study. Data was collected retrospec-
tively from the medical records of all the patients with intermedi-
ate-to-severe stenosis; and FFR or iFR was measured for the
assessment  of  hemodynamic  significance  during  the  said
period. Patients aged >18 years, presenting with moderate-to--
severe stenosis on visual estimation of the coronary angiogram
and a non-culprit vessel in patients presenting with the acute
coronary syndrome were included. For patients with an FFR
value of >0.80 and iFR value of >0.89, revascularisation was
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deferred, while it was performed where the values of FFR and
iFR were ≤0.80 and ≤0.89, respectively. In case of dissociation
in the FFR and iFR values, revascularisation was decided based
upon the FFR cutoff.
Demographics  and  clinical  characteristics  of  patients  were
assessed including comorbidities, medication history, previous
history of MI, PCI, CABG, atrial fibrillation, and stroke. The authors
further noted the target artery along with mean FFR and mean
iFR. The total numbers of FFR and IFR were recorded throughout
the study period. Post-FFR procedures were documented. Infor-
mation on the outcome was also collected for any event that
occurred after the procedure as a major adverse cardiac event
(MACE), including cardiac death, non-fatal myocardial infarction,
and target vessel revascularisation. For this purpose, cardiac
death was defined as any death in which a cardiac cause could
not be excluded. Non-fatal myocardial infarction was defined
according to the fourth universal definition of MI. Target vessel
revascularisation  (TVR)  was  defined  as  PCI  or  application  of
bypass grafts for restenosis of the previously-done FFR vessel.
The study was commenced after approval was obtained from the
Ethical Review Committee of the Hospital.
For the calculation of FFR/iFR, the Verrata plus coronary pressure
guidewire (Philips Volcano, USA) 0.014 inch was inserted into the
target artery. To achieve hyperemia during FFR measurement,
continuous  intravenous  adenosine  140/mcg/Kg/minute  was
administered through a large bore cannula for 3-4 minutes. iFR
was  calculated  using  an  automatic  algorithm  in  the  Philips
volcano  console.  The  follow-up  data  of  all  the  patients  were
collected from clinic visits or telephonic interviews. The next of
kin were interviewed in the case of patients who died. The clinical
outcomes were compared with a median follow-up of 29 months.
Data was analysed using STATA software (version 14.2; Stata-
Corp, College Station, TX). For descriptive analysis, mean and
standard deviation were calculated for quantitative variables,
while proportions were computed for qualitative variables. For
quantitative  variables,  an  independent  t-test  was  used  to
compute the difference between the two groups after assessing
normality. For inferential analysis, the groups of patients were
compared for all their characteristics using the Pearson Chi-test
and Fisher's Exact test (for qualitative variables). Cox propor-
tional  hazard  model  building  was  done  using  a  stepwise
approach, by assessing all the plausible interactions and consid-
ering a p-value <0.05 as statistically significant. In multivariable
analysis  with  Cox  proportional  hazard  regression,  diabetes
endured in the parsimonious model. In the patient-level anal-
yses, MACE, target vessel revascularisation, non-fatal MI, and
cardiovascular death were analysed with the association of nega-
tive and positive iFR, adjusted for other variables. Kaplan-Meier
curves of MACE, target vessel revascularisation, non-fatal MI and
cardiovascular death with negative and positive FFR or iFR were
compared with the log-rank test.
RESULTS
The mean age was 62.8 ± 10.80, and 71.9% of the patients were
males. Baseline characteristics of both the groups were similar,
but for the prior history of revascularisations as, shown in Table I.
The utilisation of invasive physiological assessment was <10%.
The most common indication for physiological assessment was
non-culprit artery stenosis in acute coronary syndrome (44.7%,
n=223). Twenty-two percent of the patients had moderate-to--
severe LV dysfunction (ejection fraction ≤45).
The  coronary  angiogram  indicated  multivessel  disease  in
70.1% (n=350) of the cases. The most assessed artery was LAD
(61.3%), followed by RCA (19%, Table I). Of the patients with
angiographically severe stenosis, and who would have under-
gone  revascularisation,  the  procedure  was  deferred  in  43%
(Figure 1).
Figure 1: Change in decision based on invasive physiological
assessment.
Among patients having angiographically moderate stenosis,
thus not indicated for revascularisation, 14% proceeded for
revascularisation based on physiological severity (Figure 1).
Revascularisation of the assessed artery was performed percu-
taneously in 85% and surgically in 15% of the FFR/iFR- positive
group  of  patients.  On  multivariate  regression  analysis,
diabetes (HR=2.80, 95% C.I: 1.32-5.94, p=0.007) was an inde-
pendent predictor of adverse outcomes.
The Kaplan-Meir method did not indicate a statistically signifi-
cant difference of MACE between the revascularisation-deferred
group  (6.4%  n=22)  and  revascularisation-performed  group
(8.4% n=13), as shown in Figure 2. The Kaplan-Meier curves are
shown for the comparison of MACE, target vessel revascularisa-
tion, non-fatal MI, and cardiovascular death (Figure 2).
DISCUSSION
In this study, the decision of revascularisation was changed,
based on physiological assessment in approximately a quarter
of the cases.
In the present study, MACE rates were similar on event-free
survival in both the revascularisation-performed and the revas-
cularisation-deferred groups, as shown in Figure 1.
As  proved  in  previous  literature,  the  decision  making
regarding coronary intervention can be misguided by visual
angiographic estimation of coronary lesions.3
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Age (± SD years) 62.8± 10.80 62.6± 11.05 63.2±10.23 0.589
Gender (male) 359(71.9%) 245(71%) 114(74%) 0.489
HTN 379(76%) 263(76.2%) 116(75.3%) 0.827
Diabetes 251(50.3%) 169(49%) 82(53.2%) 0.379
Dyslipidemia 263(52.7%) 185(53.6%) 78(50.6%) 0.539
Smoker 86(17.2%) 60(17.4%) 26(16.9%) 0.890
COPD 27(5.4%) 19(5.5%) 8(5.2%) 0.887
CKD 39(7.8%) 23(6.7%) 16(10.4%) 0.152
Prior MI 55(11%) 43(12.5%) 12(7.8%) 0.124
Prior CABG 12(2.4%) 12(3.5%) 0 0.022
Prior Stroke 18(3.6%) 12(3.5%) 6(3.9%) 0.817
Prior PCI 86(17.2%) 67(19.4%) 19(12.3%) 0.053
History of atrial fibrillation 14(2.8%) 12(3.5%) 2(1.3%) 0.244
Indication for procedure
ACS 223(44.7%) 151(43.8%) 72(46.8%) 0.536
CCS I 3(1%) 3(1.5%) 0
<0.001CCS II 67(23.2%) 58(29%) 9(10.1%)CCS III 204(70.6%) 135(67.5%) 69(77.5%)
CCS IV 15(5.2%) 4(2%) 11(12.4%)
Discharge medications
Aspirin 492(98.6%) 338(98%) 154(100%) 0.106           
Clopidogrel 375(75.2%) 233(67.5%) 142(92.2%) <0.001
Statin 494(99%) 340(98.6%) 154(100%) 0.330
Beta blocker 410(82.2%) 273(79.1%) 137(89%) 0.008
Calcium channel blocker 99(19.8%) 74(21.4%) 25(16.2%) 0.177
ACE inhibitors/ARBs 200(40.1%) 137(39.7%) 63(40.9%) 0.801
Ejection fraction
EF<30% 47(9.4%) 31(9%) 16(10.4%) 0.635EF 30-45% 63(12.6%) 41(11.9%) 22(14.3%)








Disease severity on visual angiographic assessment












Mean FFR 0.88±.05 0.75±.04 <0.001
Mean iFR 0.94±.03 0.81±.07 <0.001
Post physiological assessment intervention
PCI only to FFR measured lesion 0 84(54.5%)
<0.001PCI only to FFR non-measured lesion 161(46.7%) 0CABG 4(1.2%) 24(15.6%)
PCI to both FFR measured and non-measured artery 0 46(29.9%)
In this study, the change in the decision regarding revasculari-
sation observed was 24.6%, similar to that reported by Ripcord
(26%)  and  Famous  NSTEMI  (21%).12,13  However,  in  other
studies such as the Pressure-wire study (34%) and POST-IT
(45%) study, the numbers are as high as 45 %.14,15 This empha-
sised that invasive physiological assessment can guide deci-
sion-making by crossing patients over to better suited thera-
peutic strategy.
The MACE rates in the three-year follow-up of FAME 2 trials
were 10.1% in the PCI+MT group (FFR positive + PCI group),
similar to this study with MACE rate of 8.4%.16 In the COFFRS
study from India, the revascularisation group had MACE rate of
2.28%  at  18  months  follow-up.17  This  difference  in  outcomes
compared to COFFRS can be explained by the older age group
(mean age 62.8 vs. 56.3 years), longer follow-up period (29
months vs. 18 months), and the relatively higher number of
ACS patients (44.7% vs. 14%) in the present cohort.17
The  physiological  assessment-based  treatment  not  only
minimises the number of unnecessary interventions, but also
leads to better allocation of limited resources in a low- to-mid-
dle-income country. This utilisation should be increased consid-
ering  the  pronounced  economic  and  clinical  benefits  of  using
physiological assessment in decision-making. In the present
data on multivariate analysis, the independent predictor of a
MACE event was the presence of diabetes, consistent with the
data from prior studies.18,19
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Figure 2: Kaplan meir curve showing MACE, target vessel revascularisation, non-fatal MI, and cardiovascular death.
To  the  best  of  authors’  knowledge,  this  is  the  first  and
largest study on long-term outcomes of physiological assess-
ment-based revascularisation from Pakistan. These results
follow trends in outcomes similar to studies from other coun-
tries.  To  generate  a  more  robust  local  research  data,  a
prospective  multicentre  randomised  study  should  be
performed.
This study has several limitations. First, it is a single-centre
retrospective  observational  study,  and  hence  has  limited
generalisability. Second, a longer follow-up is needed to vali-
date the present results. Although the follow-up period was
indeed long, index case tracing and response from patients
were difficult for cases enrolled in the earlier years of study
induction.
CONCLUSION
Physiological assessment of coronary lesions led to a better
selection of patients for revascularisation. It prevented misla-
belling of intermediate coronary stenoses and averted unne-
cessary interventions, in turn leading to a decrease in compli-
cations of procedures, and use of dual antiplatelets.
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